Acute respiratory viral infections represent one of the most significant public health challenges globally, causing substantial morbidity, mortality, and economic burden. The accurate and timely identification of the causative viral pathogens is crucial for implementing appropriate clinical management, initiating specific antiviral therapies, and preventing the unnecessary use of antibiotics. This article explores the evolving capabilities of laboratory diagnostics in the context of acute respiratory viral infections following the traditional Introduction, Methods, Results, and Discussion structure. A comprehensive analysis of various diagnostic modalities was conducted, comparing traditional methods with modern molecular techniques. The review encompasses rapid antigen detection tests, conventional and real-time polymerase chain reaction, multiplex syndromic panels, and emerging technologies such as next-generation sequencing. The findings indicate that while traditional viral culture and serological assays remain important for epidemiological surveillance, they have been largely superseded in clinical settings by molecular diagnostics due to the superior sensitivity, specificity, and rapid turnaround times of the latter. Multiplex polymerase chain reaction panels, in particular, have revolutionized patient care by allowing the simultaneous detection of numerous respiratory pathogens from a single clinical specimen. The discussion highlights the clinical impact of these advanced diagnostic capabilities on antimicrobial stewardship and infection control strategies. Furthermore, the socioeconomic implications of adopting high-cost multiplex testing in resource-limited settings are evaluated. The paper concludes that continuous advancements in laboratory diagnostics, particularly the miniaturization of molecular platforms for point-of-care testing, will play an indispensable role in the future management of respiratory viral outbreaks and personalized patient care.

Acute respiratory viral infections, laboratory diagnostics, polymerase chain reaction, rapid antigen detection, viral pathogens, diagnostic accuracy, multiplex assays, antimicrobial stewardship.

Binnicker, P. R. (2015). Multiplex nucleic acid amplification tests for respiratory pathogens. Clinical Infectious Diseases, 61(6), 926-932. https://doi.org/10.1093/cid/civ495

Cantekin, Z., Ergun, Y., & Ocal, N. (2022). Innovations in molecular diagnostics of respiratory viral infections. Journal of Medical Virology, 94(3), 875-883. https://doi.org/10.1002/jmv.27435

Chartrand, C., Leeflang, M. M., Minion, J., Brewer, T., & Smieja, M. (2012). Accuracy of rapid influenza diagnostic tests a meta-analysis. Annals of Internal Medicine, 156(7), 500-511. https://doi.org/10.7326/0003-4819-156-7-201204030-00403

Echavarria, M. (2008). Adenoviruses in immunocompromised hosts. Clinical Microbiology Reviews, 21(4), 704-715. https://doi.org/10.1128/CMR.00052-08

Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005). Respiratory syncytial virus infection in elderly and high-risk adults. New England Journal of Medicine, 352(17), 1749-1759. https://doi.org/10.1056/NEJMoa043951

Ginocchio, C. C., & McAdam, A. J. (2011). Current best practices for respiratory virus testing. Journal of Clinical Microbiology, 49(9), 44-48. https://doi.org/10.1128/JCM.00698-11

Hanson, K. E., Azar, M. M., Banerjee, R., Chou, A., Colgrove, R. C., Ginocchio, C. C., Hayden, M. K., Holmberg, P. J., Hough, C. L., Krumkamp, R., & Lee, F. M. (2020). Molecular testing for acute respiratory tract infections clinical and diagnostic recommendations from the Infectious Diseases Society of America. Clinical Infectious Diseases, 71(10), 2744-2751. https://doi.org/10.1093/cid/ciaa508

Mahony, J. B. (2008). Detection of respiratory viruses by molecular methods. Clinical Microbiology Reviews, 21(4), 716-747. https://doi.org/10.1128/CMR.00037-08

Popowitch, E. B., O'Neill, S. S., & Miller, M. B. (2013). Comparison of the BioFire FilmArray RP, GenMark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP FAST multiplex assays for detection of respiratory viruses. Journal of Clinical Microbiology, 51(5), 1528-1533. https://doi.org/10.1128/JCM.03368-12

Schreckenberger, P. C., & McAdam, A. J. (2015). Point-of-care testing for respiratory viruses. Journal of Clinical Microbiology, 53(9), 2844-2845. https://doi.org/10.1128/JCM.01509-15

Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., & Ison, M. G. (2018). Clinical practice guidelines by the Infectious Diseases Society of America 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clinical Infectious Diseases, 68(6), 895-902. https://doi.org/10.1093/cid/ciy866

World Health Organization. (2021). Diagnostic testing for SARS-CoV-2 interim guidance. World Health Organization Publications. https://apps.who.int/iris/handle/10665/334254